Read More Pharma Industry News TCR2 Therapeutics reports positive interim results for gavo-cel in early-stage solid tumors trial TCR2 Therapeutics has reported positive interim results from its phase 1 part of the phase 1/2 clinical trial… bySrinathSeptember 18, 2021